Overview
- 145 inspections across 127 sites are on record.
- 359 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-09-24.
At a glance
Inspections
145
Sites
127
Observations
359
Career since
Aug 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lusys Laboratories, Inc. | 24 Sep 2021 | Medical Devices & Rad Health | View 483 → |
| Bio-Rad Labs | 15 Jul 2021 | Medical Devices & Rad Health | On file |
| Wipro GE Healthcare Private Ltd | 11 Feb 2020 | Medical Devices & Rad Health | |
| Aurolab Trust DBA Aurolab | 6 Feb 2020 | Medical Devices & Rad Health | View 483 → |
| Angiplast Private Limited | 30 Jan 2020 | Medical Devices & Rad Health | View 483 → |
Sites inspected
Lusys Laboratories, Inc.San Diego, United States1 insp.
Bio-Rad LabsBenicia, United States1 insp.
Wipro GE Healthcare Private LtdBengaluru, India1 insp.
Aurolab Trust DBA AurolabVeerapanjan Madurai, India1 insp.
Angiplast Private LimitedDaskroi, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Deborah K Richardson10 shared
Jennifer S King3 shared
Bleta Vuniqi1 shared
James Norman1 shared
Ian A Pilcher1 shared
Michael L Casner1 shared
Adam S Freeman1 shared
Mariappan V Chelliah1 shared
Russell A Campbell1 shared
Eric W Anderson1 shared
Full investigator report
Get the verbatim findings behind Seema S Singh's 359 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site